[vc_row][vc_column width=”1/3″][vc_widget_sidebar sidebar_id=”page-sidebar”][/vc_column][vc_column width=”2/3″][vc_column_text el_class=”titleBorder”]
[/vc_column_text][vc_column_text el_class=”bigP”]European Paediatric Translational Research Infrastructure
Funded by the European Commission Horizon 2020 programme, EPTRI arises from the need to find answers to the serious lack of medicines for children in EU and worldwide and to propose developmental models for paediatric medicines that integrate technology driven aspects with clinical trials.
Led by Consorzio per Valutazioni Biologiche e Farmacologiche (CVBF), the project aims at setting up a new complementary Research Infrastructure (RI) in the context of the existing RIs, intended to putting together and networking all the available competences and technologies useful to enhance paediatric research in paediatric medicines from drug discovery and early development phases to be translated into clinical phases and medicines uses. As partner, Penta will be providing its infrastructure, resources and long-standing experience for project coordination and support of communications activities.
For more information click here
This project has received funding from the European Union’s Horizon 2020 programme under grant agreement No. 777554.